Bethkis

Active Ingredient(s): Tobramycin
FDA Approved: * October 12, 2012
Pharm Company: * CHIESI PHARMA INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bethkis Overview

Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius that is used to treat various types of bacterial infections, particularly Gram-negative infections. It is especially effective against species of Pseudomonas.[5] It was patented in 1965, and approved for medical use in 1974.[6] Contents 1 Medical uses 1.1 Spectrum of susceptibility 2 Contraindications 3 Side effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Ph...

Read more Bethkis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tobramycin

Recent Bethkis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tobramycin
  • Injection: 1.2g, 1.2gm/vial, 1.6mg/ml, 10mg/1ml, 10mg/ml, 40mg, 40mg/ml, 60mg, 60mg/50ml, 80mg, 80mg/100ml
  • Ointment: 0.3%, 0.30%
  • Powder: 100%, 28mg
  • Powder for Reconstitution: 1.2g
  • Solution: 0.3%, 300mg/4ml, 300mg/5ml, 60mg/ml
  • Solution/drops: 0.3%, 0.30%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bethkis: (1 result)

Sorted by National Drug Code
  • 10122-820 Bethkis 300 mg/4ml Respiratory (Inhalation) Solution by Cornerstone Therapeutics Inc.

Other drugs which contain Tobramycin or a similar ingredient: (12 results)